Clinical Trial Update: Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Stable Vitiligo [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating nasal drops made from induced pluripotent stem cell–derived exosomes for treating vitiligo; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Induced pluripotent stem cell-derived exosome nasal drops

Snippet

Sponsor: Second Affiliated Hospital of Wannan Medical College | Conditions: Stable Vitiligo | EARLY_Phase 1 | Status: NOT_YET_RECRUITING